Literature DB >> 25341879

Role of xenogenous bovine platelet gel embedded within collagen implant on tendon healing: an in vitro and in vivo study.

Ahmad Oryan1, Ali Moshiri2, Abdolhamid Meimandi-Parizi3, Nicola Maffulli4.   

Abstract

Surgical reconstruction of large Achilles tendon defects is demanding. Platelet concentrates may be useful to favor healing in such conditions. The characteristics of bovine platelet-gel embedded within a collagen-implant were determined in vitro, and its healing efficacy was examined in a large Achilles tendon defect in rabbits. Two cm of the left Achilles tendon of 60 rabbits were excised, and the animals were randomly assigned to control (no implant), collagen-implant, or bovine-platelet-gel-collagen-implant groups. The tendon edges were maintained aligned using a Kessler suture. No implant was inserted in the control group. In the two other groups, a collagen-implant or bovine-platelet-gel-collagen-implant was inserted in the defect. The bioelectricity and serum platelet-derived growth factor levels were measured weekly and at 60 days post injury, respectively. After euthanasia at 60 days post injury, the tendons were tested at macroscopic, microscopic, and ultrastructural levels, and their dry matter and biomechanical performances were also assessed. Another 60 rabbits were assigned to receive no implant, a collagen-implant, or a bovine-platelet-gel-collagen-implant, euthanized at 10, 20, 30, and 40 days post injury, and their tendons were evaluated grossly and histologically to determine host-graft interactions. Compared to the control and collagen-implant, treatment with bovine-platelet-gel-collagen-implant improved tissue bioelectricity and serum platelet-derived growth factor levels, and increased cell proliferation, differentiation, and maturation. It also increased number, diameter, and density of the collagen fibrils, alignment and maturation of the collagen fibrils and fibers, biomechanical properties and dry matter content of the injured tendons at 60 days post injury. The bovine-platelet-gel-collagen-implant also increased biodegradability, biocompatibility, and tissue incorporation behavior of the implant compared to the collagen-implant alone. This treatment also decreased tendon adhesion, muscle fibrosis, and atrophy, and improved the physical activity of the animals. The bovine-platelet-gel-collagen-implant was effective in neotenon formation in vivo, which may be valuable in the clinical setting.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Tendon; biomechanics; collagen; host graft interaction; platelet gel; tissue engineering; ultrastructure

Mesh:

Substances:

Year:  2014        PMID: 25341879      PMCID: PMC4935317          DOI: 10.1177/1535370214554532

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  45 in total

1.  No effects of PRP on ultrasonographic tendon structure and neovascularisation in chronic midportion Achilles tendinopathy.

Authors:  R J de Vos; A Weir; J L Tol; J A N Verhaar; H Weinans; H T M van Schie
Journal:  Br J Sports Med       Date:  2010-11-03       Impact factor: 13.800

Review 2.  Tendon augmentation grafts: a systematic review.

Authors:  Umile Giuseppe Longo; Alfredo Lamberti; Nicola Maffulli; Vincenzo Denaro
Journal:  Br Med Bull       Date:  2010-01-04       Impact factor: 4.291

Review 3.  Platelet-rich plasma (PRP) and Platelet-Rich Fibrin (PRF): surgical adjuvants, preparations for in situ regenerative medicine and tools for tissue engineering.

Authors:  Tomasz Bielecki; David M Dohan Ehrenfest
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

4.  Does platelet-rich plasma accelerate recovery after rotator cuff repair? A prospective cohort study.

Authors:  Chris Hyunchul Jo; Ji Eun Kim; Kang Sup Yoon; Ji Ho Lee; Seung Baik Kang; Jae Hyup Lee; Hyuk Soo Han; Seung Hwan Rhee; Sue Shin
Journal:  Am J Sports Med       Date:  2011-07-07       Impact factor: 6.202

5.  Autologous platelets have no effect on the healing of human achilles tendon ruptures: a randomized single-blind study.

Authors:  Thorsten Schepull; Joanna Kvist; Hanna Norrman; Marie Trinks; Gösta Berlin; Per Aspenberg
Journal:  Am J Sports Med       Date:  2010-11-03       Impact factor: 6.202

6.  Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system.

Authors:  Gernot Weibrich; Wilfried K G Kleis; Gerd Hafner
Journal:  Int J Oral Maxillofac Implants       Date:  2002 Mar-Apr       Impact factor: 2.804

Review 7.  Tendon injury and tendinopathy: healing and repair.

Authors:  Pankaj Sharma; Nicola Maffulli
Journal:  J Bone Joint Surg Am       Date:  2005-01       Impact factor: 5.284

8.  The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise.

Authors:  B Czarkowska-Paczek; I Bartlomiejczyk; J Przybylski
Journal:  J Physiol Pharmacol       Date:  2006-06       Impact factor: 3.011

9.  Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial.

Authors:  Robert J de Vos; Adam Weir; Hans T M van Schie; Sita M A Bierma-Zeinstra; Jan A N Verhaar; Harrie Weinans; Johannes L Tol
Journal:  JAMA       Date:  2010-01-13       Impact factor: 56.272

Review 10.  Xenogeneic extracellular matrix as a scaffold for tissue reconstruction.

Authors:  Stephen F Badylak
Journal:  Transpl Immunol       Date:  2004-04       Impact factor: 1.708

View more
  2 in total

1.  The effect of the platelet-rich plasma and ozone therapy on tendon-to-bone healing in the rabbit rotator cuff repair model.

Authors:  Murat Gurger; Gokhan Once; Erhan Yilmaz; Sukru Demir; Ilknur Calik; Yakup Say; Ahmet Kavakli; Sefa Key; Mustafa Umit Gurbuz; Onur Bingollu
Journal:  J Orthop Surg Res       Date:  2021-03-19       Impact factor: 2.359

2.  Healing potentials of polymethylmethacrylate bone cement combined with platelet gel in the critical-sized radial bone defect of rats.

Authors:  Ahmad Oryan; Soodeh Alidadi; Amin Bigham-Sadegh; Ali Moshiri
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.